// App-Quantinova.ai

3837 : Passenger deletion of ENO1 as a collateral lethality target in cancer

Researchers

Presenter

  • Yu-Hsi Lin

Principal Investigators

  • Nikunj Satani

  • Naima Hammoudi

  • Joe Marszalek

  • Yuting Sun

  • Marina Protopopova

  • Maria E. Di Francesco

  • Barbara Czako

  • Alan Wang

  • Ronald A. DePinho

  • Florian L. Muller

Medical Centers

  • The University of Texas MD Anderson Cancer Canter, Houston, TX

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Liver cancer

  • Advanced biliary tract carcinoma

  • Glioblastoma

  • Solid malignancies

  • Gliomas

Biomarkers

  • Enolase 2

Drug/Treatment

  • Mubritinib

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved